BRPI0506041A - proteìna indutora de angiogênese acelerada, composições indutoras de angiogênese acelerada e usos de proteìna indutora de angiogênese acelerada - Google Patents

proteìna indutora de angiogênese acelerada, composições indutoras de angiogênese acelerada e usos de proteìna indutora de angiogênese acelerada

Info

Publication number
BRPI0506041A
BRPI0506041A BRPI0506041-9A BRPI0506041A BRPI0506041A BR PI0506041 A BRPI0506041 A BR PI0506041A BR PI0506041 A BRPI0506041 A BR PI0506041A BR PI0506041 A BRPI0506041 A BR PI0506041A
Authority
BR
Brazil
Prior art keywords
inducing
accelerated angiogenesis
angiogenesis
accelerated
protein
Prior art date
Application number
BRPI0506041-9A
Other languages
English (en)
Inventor
Joaquim Coutinho Netto
Original Assignee
Pele Nova Biotecnologia S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pele Nova Biotecnologia S A filed Critical Pele Nova Biotecnologia S A
Priority to BRPI0506041-9A priority Critical patent/BRPI0506041B1/pt
Priority to EP06817632.0A priority patent/EP1963356B1/en
Priority to US12/094,931 priority patent/US8338371B2/en
Priority to PCT/BR2006/000253 priority patent/WO2007059597A2/en
Publication of BRPI0506041A publication Critical patent/BRPI0506041A/pt
Publication of BRPI0506041B1 publication Critical patent/BRPI0506041B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROTEìNA INDUTORA DE ANGIOGêNESE ACELERADA, COMPOSIçõES INDUTORAS DE ANGIOGêNESE ACELERADA E USOS DE PROTEìNA INDUTORA DE ANGIOGêNESE ACELERADA A presente invenção refere-se a uma proteína indutora de angiogênese, a uma composição que a contém, bem como aos usos de dita proteína.
BRPI0506041-9A 2005-11-24 2005-11-24 Composição indutora de angiogênese acelerada e usos de uma proteína indutora de angiogênese acelerada BRPI0506041B1 (pt)

Priority Applications (4)

Application Number Priority Date Filing Date Title
BRPI0506041-9A BRPI0506041B1 (pt) 2005-11-24 2005-11-24 Composição indutora de angiogênese acelerada e usos de uma proteína indutora de angiogênese acelerada
EP06817632.0A EP1963356B1 (en) 2005-11-24 2006-11-24 Accelerated angiogenesis-inducing protein, compositions inducing accelerated angiogenesis and uses thereof
US12/094,931 US8338371B2 (en) 2005-11-24 2006-11-24 Accelerated angiogenesis-inducing protein, compositions inducing accelerated angiogenesis and uses thereof
PCT/BR2006/000253 WO2007059597A2 (en) 2005-11-24 2006-11-24 Accelerated angiogenesis-inducing protein, compositions inducing accelerated angiogenesis and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0506041-9A BRPI0506041B1 (pt) 2005-11-24 2005-11-24 Composição indutora de angiogênese acelerada e usos de uma proteína indutora de angiogênese acelerada

Publications (2)

Publication Number Publication Date
BRPI0506041A true BRPI0506041A (pt) 2007-08-14
BRPI0506041B1 BRPI0506041B1 (pt) 2021-09-14

Family

ID=38067561

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0506041-9A BRPI0506041B1 (pt) 2005-11-24 2005-11-24 Composição indutora de angiogênese acelerada e usos de uma proteína indutora de angiogênese acelerada

Country Status (4)

Country Link
US (1) US8338371B2 (pt)
EP (1) EP1963356B1 (pt)
BR (1) BRPI0506041B1 (pt)
WO (1) WO2007059597A2 (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457093A (en) 1987-09-18 1995-10-10 Ethicon, Inc. Gel formulations containing growth factors
DE69535434T2 (de) * 1994-09-16 2007-06-28 The Board Of The Rubber Research Institute Of Malaysia Allergieauslösendes Protein Hev b II aus natürlichem Gummi-Latex, Herstellung und Anwendung in Nachweismethoden
BR9604371B8 (pt) 1996-10-09 2021-06-22 Antonio Cesar Da Silva Zborowski biomembrana adequada para uso na substituição, reconstrução, indução de angiogênese, neoformação ou regeneração de tecidos ou órgãos humanos e animais, material substituto, uso da biomembrana e suporte para o crescimento de microorganismos e células.
MY119235A (en) * 2000-12-21 2005-04-30 Matang Mfg Sdn Bhd Aloe vera impregnated elastomeric article and method of manufacture
MY139558A (en) * 2003-02-28 2009-10-30 Malaysian Rubber Board A protein
AR046499A1 (es) 2003-07-18 2005-12-14 Pele Nova Biotecnologia S A Membranas de latex microporoso, metodos de realizacion de las mismas y articulos relacionados

Also Published As

Publication number Publication date
EP1963356B1 (en) 2015-08-19
WO2007059597A8 (en) 2007-09-13
EP1963356A2 (en) 2008-09-03
US20090093404A1 (en) 2009-04-09
WO2007059597A2 (en) 2007-05-31
US8338371B2 (en) 2012-12-25
BRPI0506041B1 (pt) 2021-09-14

Similar Documents

Publication Publication Date Title
CR10528A (es) Proceso para producir poxvirus y composiciones de poxvirus
CU23978B1 (es) Composiciones para anticuerpos que se dirigen a la proteína de complemento c5
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
PA8671301A1 (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
GT200600181A (es) Derivados de amida sustituida y metodos de uso
BRPI0606687A2 (pt) composições nutracêuticas
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
BR112013000682A2 (pt) composições alimentícias tendo aparência e textura similares à carne realísticas
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
ECSP109968A (es) Depsipéptidos cíclicos
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
BR112013006038A2 (pt) adesivos de soja e compostos feitos de adesivos.
EA200801676A1 (ru) Комбинация производных триазина и сенсибилизаторов инсулина
HN2010000330A (es) DERIVADOS DE INDOL-2-ONA DISUSTITUIDOS EN 3 y SU PREPARACION
BRPI0603785A (pt) lubrifcante pessoal borrifável
UY29417A1 (es) Agentes endoparasiticidas
BR112013000840A2 (pt) método para aumentar o efeito de forma ativada potencializada de anticorpo para molécula endógena biológica, composição farmacêutica e uso de combinação de molécula biológica endógena com forma ativada potencializada de anticorpo para a sintase no endotelial.
BRPI0603784A (pt) lubrificante pessoal vaporizável
DOP2012000156A (es) Nuevos derivados de (heterociclo-piperidina condensada)-(piperazini)-1-alcanona o de (heterociclo-pirrolidina condensada)-(piperazinil)-1-alcanona y su utilizacion como inhibidores de p75
UY29371A1 (es) Pirroles sustituídos, composiciones que los contienen, proceso de fabricación y utilización
BRPI0519812A2 (pt) método para a obtenção de células de algas castanhas liofilizadas
ATE552832T1 (de) Antidepressivum-propharmaka
UY31139A1 (es) Formas cristalinas de 3-(2r-tetrahidrofuril-metil)-2-tioxantina
CY1112501T1 (el) Φαρμακευτικες συνθεσεις περιεχουσες λεφλουνομιδη

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B25G Requested change of headquarter approved

Owner name: PELE NOVA BIOTECNOLOGIA S.A (BR/SP)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/11/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.